1. Will other drugmakers end up with deals like Endo’s $10M opioid settlement? — AstraZeneca Imfinzi combo fails advanced lung cancer study — FDA says they were “lucky” with Novartis data manipulation controversy — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. What happened a year ago this week in biopharma? Regeneron’s Eylea approval, Novartis’ new ethics czar, Vertex’s Kalydeco, and Opidvo’s SCLC approval click to review and read a current update of the big stories from one year ago
    Dismiss Notice

Upper Management Update - UBU Update

Discussion in 'Alza' started by Anonymous, Oct 6, 2006 at 11:11 AM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Jay wasn't the leader there, Butler was. Jay didn't do anything without Butler's ok.
     
  2. Anonymous

    Anonymous Guest

    How about a 2013 update?
     
  3. Anonymous

    Anonymous Guest

    How about a 2014 update?